Abstract
G Protein-Coupled Receptors (GPCRs) are the most targeted group of proteins for the development of therapeutic drugs. Until the last decade, structural information about this family of membrane proteins was relatively scarce, and their mechanisms of ligand binding and signal transduction were modeled on the assumption that GPCRs existed and functioned as monomeric entities. New crystal structures of native and engineered GPCRs, together with important biochemical and biophysical data that reveal structural details of the activation mechanism(s) of this receptor family, provide a valuable framework to improve dynamic molecular models of GPCRs with the ultimate goal of elucidating their allostery and functional selectivity. Since the dynamic movements of single GPCR protomers are likely to be affected by the presence of neighboring interacting subunits, oligomeric arrangements should be taken into account to improve the predictive ability of computer-assisted structural models of GPCRs for effective use in drug design.
Keywords: GPCRs, molecular modeling, dynamics, activation, dimerization, oligomerization
Current Pharmaceutical Design
Title: Progress in Elucidating the Structural and Dynamic Character of G Protein-Coupled Receptor Oligomers for Use in Drug Discovery
Volume: 15 Issue: 35
Author(s): A. Bortolato, J. C. Mobarec, D. Provasi and M. Filizola
Affiliation:
Keywords: GPCRs, molecular modeling, dynamics, activation, dimerization, oligomerization
Abstract: G Protein-Coupled Receptors (GPCRs) are the most targeted group of proteins for the development of therapeutic drugs. Until the last decade, structural information about this family of membrane proteins was relatively scarce, and their mechanisms of ligand binding and signal transduction were modeled on the assumption that GPCRs existed and functioned as monomeric entities. New crystal structures of native and engineered GPCRs, together with important biochemical and biophysical data that reveal structural details of the activation mechanism(s) of this receptor family, provide a valuable framework to improve dynamic molecular models of GPCRs with the ultimate goal of elucidating their allostery and functional selectivity. Since the dynamic movements of single GPCR protomers are likely to be affected by the presence of neighboring interacting subunits, oligomeric arrangements should be taken into account to improve the predictive ability of computer-assisted structural models of GPCRs for effective use in drug design.
Export Options
About this article
Cite this article as:
Bortolato A., Mobarec C. J., Provasi D. and Filizola M., Progress in Elucidating the Structural and Dynamic Character of G Protein-Coupled Receptor Oligomers for Use in Drug Discovery, Current Pharmaceutical Design 2009; 15 (35) . https://dx.doi.org/10.2174/138161209789824768
DOI https://dx.doi.org/10.2174/138161209789824768 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Endothelial-Mesenchymal Transition (EndMT) and Tissue Regeneration
Current Stem Cell Research & Therapy Plasticity and Maintenance of Hematopoietic Stem Cells During Development
Recent Patents on Biotechnology T Cell Homeostasis in Centenarians: From the Thymus to the Periphery
Current Pharmaceutical Design Perspectives in Cell Cycle Regulation: Lessons from an Anoxic Vertebrate
Current Genomics Organic Antifungal Drugs and Targets of Their Action
Current Topics in Medicinal Chemistry Nucleic Acid Aptamers Against Protein Kinases
Current Medicinal Chemistry Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides
Current HIV Research Gold Nanoparticle Based Systems in Genetics
Current Pharmacogenomics Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture On Various Metrics Used for Validation of Predictive QSAR Models with Applications in Virtual Screening and Focused Library Design
Combinatorial Chemistry & High Throughput Screening The Role of Oxidative Stress in Smoking-Related Diseases
Mini-Reviews in Organic Chemistry Polypharmacology of Approved Anticancer Drugs
Current Drug Targets Overcoming Drug Resistance and Treating Advanced Prostate Cancer
Current Drug Targets Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma on Cirrhosis: State of the Art and Future Perspectives
Recent Patents on Anti-Cancer Drug Discovery G Protein-Coupled Receptor Signaling Complexity in Neuronal Tissue:Implications for Novel Therapeutics
Current Alzheimer Research Recent Advances in Predicting Protein Classification and Their Applications to Drug Development
Current Topics in Medicinal Chemistry GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
Current Medicinal Chemistry Three-Dimensional Structural Analysis of the Binding Site of Two Inhibitors, Nervonic Acid and Lithocholic Acid, of DNA Polymerase β and DNA Topoisomerase II
Current Computer-Aided Drug Design An Overview of Recent Patents on Nanoparticles for Drug Delivery Across the Blood Brain Barrier
Recent Patents on Nanomedicine Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry